These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 8239496)

  • 21. Comparison of lipid content, surface membrane fluidity, and temperature dependence of cis-diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells.
    Mann SC; Andrews PA; Howell SB
    Anticancer Res; 1988; 8(6):1211-5. PubMed ID: 3218956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel mechanisms of platinum drug resistance identified in cells selected for resistance to JM118 the active metabolite of satraplatin.
    Samimi G; Kishimoto S; Manorek G; Breaux JK; Howell SB
    Cancer Chemother Pharmacol; 2007 Feb; 59(3):301-12. PubMed ID: 16770583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Study of ceramide monohexoside in ovarian cell line COC1/DDP resistant to cisplantin].
    Qin TN; Wang LL; Chen HG; Gao QH; Zhou RX; Sun BZ; Wang QW
    Zhonghua Fu Chan Ke Za Zhi; 2003 Sep; 38(9):556-9. PubMed ID: 14680612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyperthermic potentiation of cis-diamminedichloroplatinum(II) cytotoxicity in Chinese hamster ovary cells resistant to the drug.
    Wallner KE; DeGregorio MW; Li GC
    Cancer Res; 1986 Dec; 46(12 Pt 1):6242-5. PubMed ID: 3779644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation between cell killing by cis-diamminedichloroplatinum(II) in six mammalian cell lines and binding of a cis-diamminedichloroplatinum(II)-DNA antiserum.
    Terheggen PM; Emondt JY; Floot BG; Dijkman R; Schrier PI; den Engelse L; Begg AC
    Cancer Res; 1990 Jun; 50(12):3556-61. PubMed ID: 2340504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. P53 modulates the effect of loss of DNA mismatch repair on the sensitivity of human colon cancer cells to the cytotoxic and mutagenic effects of cisplatin.
    Lin X; Ramamurthi K; Mishima M; Kondo A; Christen RD; Howell SB
    Cancer Res; 2001 Feb; 61(4):1508-16. PubMed ID: 11245458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinetics and mechanism of the 1-beta-D-arabinofuranosylcytosine-induced potentiation of cis-diamminedichloroplatinum(II) cytotoxicity.
    Vadi H; Drewinko B
    Cancer Res; 1986 Mar; 46(3):1105-9. PubMed ID: 3080232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resistance of in vitro grown IgM immunocytoma cells to cis-diamminedichloroplatinum (II) (cis-DDP) and cross-resistance to other DNA interacting drugs.
    Vendrik CP; de Jong WH; Van der Minnen AC; Fichtinger-Schepman AM; Steerenberg PA; Schornagel JH
    Anticancer Res; 1990; 10(2A):447-52. PubMed ID: 2346318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Establishment of human ovarian cancer cisplatin resistant cell line COC1/DDP and its mechanism of resistance].
    Zhou Y; Chen H; Yang Q
    Zhonghua Yi Xue Za Zhi; 1996 Sep; 76(9):680-3. PubMed ID: 9275551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cross-resistance between cisplatin and antimony in a human ovarian carcinoma cell line.
    Naredi P; Heath DD; Enns RE; Howell SB
    Cancer Res; 1994 Dec; 54(24):6464-8. PubMed ID: 7987844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Enhanced sensitivity of ovarian cell line to cisplatin induced by mifepristone and its mechanism].
    Qin TN; Wang LL
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Apr; 22(4):344-6. PubMed ID: 12390742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of a cisplatin-resistant subline of murine RIF-1 cells and reversal of drug resistance by hyperthermia.
    Mansouri A; Henle KJ; Benson AM; Moss AJ; Nagle WA
    Cancer Res; 1989 May; 49(10):2674-8. PubMed ID: 2713851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paradoxical increase in DNA cross-linking in a human ovarian carcinoma cell line resistant to cyanomorpholino doxorubicin.
    Lau DH; Ross KL; Sikic BI
    Cancer Res; 1990 Jul; 50(13):4056-60. PubMed ID: 2162251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transport of cisplatin and bis-acetato-ammine-dichlorocyclohexylamine Platinum(IV) (JM216) in human ovarian carcinoma cell lines: identification of a plasma membrane protein associated with cisplatin resistance.
    Sharp SY; Rogers PM; Kelland LR
    Clin Cancer Res; 1995 Sep; 1(9):981-9. PubMed ID: 9816070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperthermic modulation of resistance to cis-diamminedichloroplatinum (II) in human larynx carcinoma cells.
    Beketić-Oresković L; Jaksić M; Oresković S; Osmak M
    Int J Hyperthermia; 1997; 13(2):205-14. PubMed ID: 9147146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thaliblastine, a plant alkaloid, circumvents multidrug resistance by direct binding to P-glycoprotein.
    Chen G; Ramachandran C; Krishan A
    Cancer Res; 1993 Jun; 53(11):2544-7. PubMed ID: 8098661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increase of cisplatin sensitivity by c-myc antisense oligodeoxynucleotides in a human metastatic melanoma inherently resistant to cisplatin.
    Leonetti C; Biroccio A; Candiloro A; Citro G; Fornari C; Mottolese M; Del Bufalo D; Zupi G
    Clin Cancer Res; 1999 Sep; 5(9):2588-95. PubMed ID: 10499637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of apoptosis in four human tumour cell lines with differing sensitivities to cisplatin.
    Raaphorst GP; Mao J; Yang H; Goel R; Niknafs B; Shirazi FH; Yazdi HM; Rippstein P; Ng CE
    Anticancer Res; 1998; 18(4C):2945-51. PubMed ID: 9713489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination chemotherapy of paclitaxel and cisplatin induces apoptosis with Bcl-2 phosphorylation in a cisplatin-resistant human epidermoid carcinoma cell line.
    Sawada S; Mese H; Sasaki A; Yoshioka N; Matsumura T
    Cancer Chemother Pharmacol; 2003 Jun; 51(6):505-11. PubMed ID: 12709826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative genomic hybridization analysis of chromosomal changes occurring during development of acquired resistance to cisplatin in human ovarian carcinoma cells.
    Wasenius VM; Jekunen A; Monni O; Joensuu H; Aebi S; Howell SB; Knuutila S
    Genes Chromosomes Cancer; 1997 Apr; 18(4):286-91. PubMed ID: 9087568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.